These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903 [TBL] [Abstract][Full Text] [Related]
3. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653 [TBL] [Abstract][Full Text] [Related]
4. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ. Wang H; Feng D; Park O; Yin S; Gao B Hepatology; 2013 Oct; 58(4):1474-85. PubMed ID: 23686838 [TBL] [Abstract][Full Text] [Related]
5. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide. Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285 [TBL] [Abstract][Full Text] [Related]
6. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913 [TBL] [Abstract][Full Text] [Related]
7. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273 [TBL] [Abstract][Full Text] [Related]
8. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment. Duthie MS; Kahn SJ Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622 [TBL] [Abstract][Full Text] [Related]
9. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491 [TBL] [Abstract][Full Text] [Related]
10. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
11. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815 [TBL] [Abstract][Full Text] [Related]
12. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide. Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160 [TBL] [Abstract][Full Text] [Related]
13. Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-γ- and IL-4-dependent mechanisms. Yin S; Wang H; Bertola A; Feng D; Xu MJ; Wang Y; Gao B Hepatology; 2014 Oct; 60(4):1356-66. PubMed ID: 24623351 [TBL] [Abstract][Full Text] [Related]
14. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
15. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507 [TBL] [Abstract][Full Text] [Related]
16. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis. Bharhani MS; Chiu B; Na KS; Inman RD Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617 [TBL] [Abstract][Full Text] [Related]
18. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104 [TBL] [Abstract][Full Text] [Related]
19. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399 [TBL] [Abstract][Full Text] [Related]
20. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]